These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16763801)

  • 21. [Not Available].
    Rofo; 2017 Nov; 189(11):1106-1111. PubMed ID: 29073715
    [No Abstract]   [Full Text] [Related]  

  • 22. [Focus on academic multicenter trials: impact of the German drug law on hematological/oncological therapy optimization trials].
    Ihrig K; Fath B; Fuchs M; Hallek M; Marschner N; Naumann R; Röllig C; Saussele S; Tesch H; Gökbuget N
    Onkologie; 2013; 36 Suppl 2():23-8. PubMed ID: 23549033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The community clinical trial system EudraCT at the EMEA for the monitoring of clinical trials in Europe].
    Krafft H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):453-8. PubMed ID: 15830257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Decree on the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use].
    Schwerdtfeger WK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):147-54. PubMed ID: 15726455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statement of the German Contact Dermatitis Research Group (DKG) and the German Dermatological Society (DDG) on liability issues associated with patch testing using a patient's own materials.
    Mahler V; Dickel H; Diepgen TL; Hillen U; Geier J; Kaufmann R; Kreft B; Schnuch A; Szliska C; Bender A
    J Dtsch Dermatol Ges; 2017 Feb; 15(2):202-204. PubMed ID: 27791337
    [No Abstract]   [Full Text] [Related]  

  • 27. [New Japanese GCP--from the standpoint of a sponsor].
    Ebi O
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):650-62. PubMed ID: 9571962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Basic principles, planning and implementation of non-commercial clinical trials].
    Finger RP; Coch C; Coenen M; Mengel M; Hartmann G; Holz FG
    Ophthalmologe; 2011 Jan; 108(1):25-32. PubMed ID: 21181167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reaching Safe Harbor: Legal Implications of Clinical Practice Guidelines.
    Oza VM; El-Dika S; Adams MA
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):172-4. PubMed ID: 26702951
    [No Abstract]   [Full Text] [Related]  

  • 30. [Quality requirements governing non-commercial clinical trials within the framework of clinical drug development in humans in the EU. Challenges, opportunities, and questions experienced by treatment centres].
    Boos J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):196-203. PubMed ID: 15726461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Legal aspects of the responsibility of nurses in clinical testing of drugs].
    Röhlig HW
    Krankenpflege (Frankf); 1991 Feb; 45(2):82-3. PubMed ID: 1902894
    [No Abstract]   [Full Text] [Related]  

  • 32. [Legal liability in drug trials].
    Frölich JC
    Z Arztl Fortbild (Jena); 1995 Nov; 89(6):641-6. PubMed ID: 8588438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Institutional conflicts of interest and research with human subjects.
    Maloney DM
    Hum Res Rep; 2003 Feb; 18(2):1-2. PubMed ID: 12814111
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recommended guidelines--binding or non-binding?].
    Prudil L
    Ceska Gynekol; 2011 Sep; 76(4):251. PubMed ID: 22026063
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reporting of harms in clinical trials: Vigilant support to the investigator. A guideline of REVISE' Group].
    Marfin H; Fedrizzi S; Crépin S; Parienti JJ; Gimbert A; Blandamour V; Diallo A; Defer G; Bertram D; Peyro Saint Paul L;
    Therapie; 2016 Oct; 71(5):475-481. PubMed ID: 27423828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The legal status of clinical and ethics policies, codes, and guidelines in medical practice and research.
    Campbell A; Glass KC
    McGill Law J; 2001 Feb; 46(2):473-89. PubMed ID: 16523580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic trial, clinical research and therapeutic freedom--legal boundaries].
    Deutsch E
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):698-700; discussion 701. PubMed ID: 9527472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of Investigator-Initiated Clinical Trials with a Pharmaceutical for Cancer Patients before and after Post-Millennial Changes of Regulations in Germany and Europe.
    Berdel WE
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Participation by the established physician in clinical drug trials].
    Broglie MG
    Z Gesamte Inn Med; 1990 Dec; 45(23):717-8. PubMed ID: 2102028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The legal form of "medizinische versorgungszentren"].
    Siegert M; Wasem J; von Knoch M
    Gesundheitswesen; 2007 Apr; 69(4):224-6. PubMed ID: 17533564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.